Search For "sahil"
Dr Reddy's denied approval for Phase 3 trials of Sputnik Light Covid-19 va
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): The central government's Subject Expert Committee (SEC) has denied permission to Dr Reddy's Laboratories for conducting Phase 3 trials of Russia's COVID-19 vaccine Sputnik Light in India.
Read More
Bharat Biotech to soon start Covaxin manufacturing facility in Bengaluru
Updated : 4 years, 8 months ago IST
New Delhi [India], June 30 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech on Wednesday said that the company hopes to start manufacturing its COVID-19 vaccine Covaxin in Bengaluru soon.
Read More
People living with HIV/AIDS may be less susceptible to COVID: AIIMS study
Updated : 4 years, 8 months ago IST
New Delhi [India], June 30 (ANI): The presence of antibodies, or the seroprevelance against the SARS-CoV-2 was found to be lower among people living with HIV and AIDS according to a study by the All India Institute of Medical Sciences (AIIMS) in Delhi.
Read More
Bharat Biotech denies receiving advance payments, supplying vaccines to Br
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], June 30 (ANI): Issuing clarification on COVAXIN pricing controversy in Brazil, Bharat Biotech on Tuesday said it followed a step-by-step regulatory approval process during the eight-month period, but the company has neither received any advance payments nor
Read More
Third-wave unlikely to be as severe as second wave: ICMR study
Updated : 4 years, 8 months ago IST
New Delhi [India], June 25 (ANI): A study done by the Indian Council of Medical Research (ICMR) has found that the substantial third wave of COVID-19 could occur but it may not be as severe as the second wave.
Read More
'If we are disciplined, then we can stay safe,' says Health Ministry on CO
Updated : 4 years, 8 months ago IST
New Delhi [India], June 22 (ANI): The government has cautioned people not to lower their guard against COVID-19, in view of a likely third-wave peak of the pandemic.
Read More
COVID-19's third wave peak expected around September-October: IIT Kanpur s
Updated : 4 years, 8 months ago IST
New Delhi [India], June 21 (ANI): An IIT Kanpur study done by Prof. Rajesh Ranjan and Mahendra Verma, along with their team, on Monday said third wave peak of COVID could be around September - October this year.
Read More
COVID-19: Centre directs states, UTs to ensure safety of healthcare worker
Updated : 4 years, 8 months ago IST
New Delhi [India], June 18 (ANI): The Union Health Ministry on Friday wrote a letter to all states and Union Territories (UTs) asking them to undertake a detailed review to ensure that prompt and necessary steps are taken for the safety and well-being of healthcare workers (HCWs) besides
Read More
Studies show chances of hospitalisation among HCWs reduce by 75-80 pc afte
Updated : 4 years, 9 months ago IST
New Delhi [India], June 18 (ANI): Studies have shown that after COVID-19 vaccination the chances of hospitalisation among healthcare workers (HCWs) reduce by 75-80 per cent even after contracting the infection, the health ministry said in a briefing on Friday.
Read More
Novavax's COVID-19 vaccine 'Covavax' to launch in India by September: Sour
Updated : 4 years, 9 months ago IST
New Delhi [India], June 17 (ANI): The Serum Institute of India (SII) hopes to introduce US firm Novavax's Indian version of the COVID-19 vaccine - 'Covavax' by September this year and start trials on children from July.
Read More
SSR drug case: Bombay HC rejects drug peddler Sahil Shah's anticipatory ba
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 15 (ANI): Bombay High Court on Tuesday dismissed the anticipatory bail plea of alleged drug peddler Sahil Shah in connection with the drug case related to actor Sushant Singh Rajput.
Read More
COVID-19 'Delta Plus' variant detected in India, nullifies monoclonal anti
Updated : 4 years, 9 months ago IST
New Delhi [India], June 15 (ANI): The Union Health Ministry on Tuesday revealed that the Delta variant with an additional mutation known as "Delta Plus" has been detected in the country that nullifies the use of monoclonal antibody but asserted that it still not a "variant of concern". Read More
